CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Continente #
EU - Europa 3.917
NA - Nord America 3.632
AS - Asia 1.242
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
AF - Africa 2
OC - Oceania 2
Totale 8.813
Nazione #
US - Stati Uniti d'America 3.618
IE - Irlanda 1.282
CN - Cina 919
UA - Ucraina 769
SE - Svezia 556
IT - Italia 443
BE - Belgio 341
FR - Francia 186
TR - Turchia 152
FI - Finlandia 119
IN - India 101
GB - Regno Unito 95
DE - Germania 61
VN - Vietnam 40
CA - Canada 14
IR - Iran 12
RO - Romania 12
RU - Federazione Russa 12
EU - Europa 10
CZ - Repubblica Ceca 6
NL - Olanda 6
RS - Serbia 6
GR - Grecia 5
TH - Thailandia 4
AT - Austria 3
BR - Brasile 3
CL - Cile 3
ES - Italia 3
JO - Giordania 3
SG - Singapore 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
HK - Hong Kong 2
MT - Malta 2
PT - Portogallo 2
BD - Bangladesh 1
CI - Costa d'Avorio 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
PS - Palestinian Territory 1
Totale 8.813
Città #
Dublin 1.282
Chandler 588
Jacksonville 539
Dearborn 455
Brussels 340
Nyköping 331
Nanjing 276
Ashburn 205
Wilmington 175
Beijing 137
Princeton 122
Nanchang 102
San Mateo 102
Ann Arbor 99
Woodbridge 72
Shenyang 70
Des Moines 64
New York 57
Foggia 54
Boardman 46
Hebei 43
Tianjin 42
Kunming 41
Jiaxing 39
Dong Ket 38
Helsinki 32
Pune 29
Changsha 26
Rome 26
Bari 24
Jinan 24
Seattle 24
Hangzhou 20
Philadelphia 19
Auburn Hills 17
Ningbo 15
Changchun 14
Stevenage 13
Zhengzhou 13
Augusta 12
London 12
Washington 12
Hilden 11
Taizhou 11
Bologna 9
Hefei 9
Lanzhou 9
Toronto 9
Los Angeles 8
Orange 8
Guangzhou 7
Redwood City 7
Timisoara 7
Brno 6
Leawood 6
Shanghai 6
Ardabil 5
Dallas 5
Milan 5
Saint Petersburg 5
Bangkok 4
Capua 4
Catania 4
Chicago 4
Florence 4
Hanover 4
Houston 4
Manfredonia 4
San Marzano Di San Giuseppe 4
Turin 4
Walnut 4
Bellante 3
Borås 3
Jesi 3
Kozani 3
Mola Di Bari 3
Naples 3
Napoli 3
Nettuno 3
Norwalk 3
Padova 3
Racale 3
Reggio Calabria 3
Serramazzoni 3
Alghero 2
Belford Roxo 2
Belgrade 2
Bollate 2
Botosani 2
Bracknell 2
Campobasso 2
Cascais 2
Cedar Knolls 2
Cerignola 2
Civitanova Marche 2
Columbus 2
Corato 2
Cuggiono 2
Edinburgh 2
Fairfield 2
Totale 5.899
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 202
Il fenetil estere dell'acido caffeico è un potente inibitore della via metabolica 5-lipossigenasica/leucotrienica 197
Sviluppo ed applicazione di un protocollo di desensibilizzazione rapida per Rituximab 155
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia crociata a fico e gelsi 130
Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. 115
"Metodo diagnostico in vitro per allergia respiratoria da polline di Cupressus arizonica". 115
5-lipoxygenase upregulation by dexamethasone in human mast cells. 115
Allergy to artichoke: a case report. 114
Terapia con Omalizumab nell'asma severo persistente: presentazione di un caso clinico 113
Apoptosis induced by the Fusarium mycotoxin beauvericin in mammalian cells. 110
Allergia alimentare a Leguminose della dieta mediterranea: Phaseoulus vulgaris (fagiolo) e Pisum Sativum (pisello) 109
Fusaproliferin production by Fusarium subglutinans and toxicity to Artemia salina, SF-9 insect cells and IARC/LCL 171 human B-lymphocytes. 108
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet 103
Allergia alimentare da finocchio (Phoeniculum Vulgare) ed altre Apiaceae 103
Terapia con Omalizumab: valutazione di efficacia e tollerabilità in una casistica di 21 soggetti con asma severo non controllato 101
Olive pollen allergy in Bari, Italy. 99
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evedence for a noncopetitive mode of action 99
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia al carciofo 99
Sviluppo ed applicazione di una procedura di monitoring dell'asma persistente basato su registrazione di sintomi e PEF 98
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy. 97
Tako-tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 94
Grape anaphylaxis 93
Flaws and improvement in skin testing in Hymenoptera venom allergy. 93
Development and application of an improved sympton score and PEF card-based procedure in the management of persistent asthma 92
General adverse reaction to aspirin administered by transdermal iontophoresis. 92
Allergeni alimentari emergenti della dieta mediterranea 91
Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components. 90
Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term 90
Biosensori cellulari nella valutazione di nuovi detergenti ecosostenibili. 89
Beauvericin cytotoxicity to the invertebrate cell line SF-9. 89
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet. 89
Five-lipoxygenase/leukotreiene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-infiammatory properties. 88
Cyclooxygenase-2 expression in oral squamous cell carcinoma 88
Omalizumab in severe allergic asthma: efficacy assessment by comparison of pre- and post-therapy symptom score and peak espiratory flow (PEF) values. 87
Allergy to pomegranate and artichoke, novel food allergens of the mediterranean diet. 87
EFFETTI DEL MONTELUKAST SULLA BIOSINTESI DEI LEUCOTRIENI E SULL'ATTIVITA' ENZIMATICA DELLA 5-LO 85
Allergia alimentare da finocchio (Phoeniculum vulgare) ed altre Apiaceae 85
Changes in skin reactivity, specific IgE and IgG levels after 1 year of immunotherapy in olive pollinosis. 84
Airborne Cupressaceae pollen in Southern Italy 84
A new subcutaneous protocol for persistent desensitisation to Rituximab. 84
Wasp immunotherapy induces a long term and IgG4-independent protection. 84
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen 80
Significativo declino dei valori di IgE specifiche legate, evidenziato da skin prick tests quantitativi, in pazienti con asma severo trattati con omalizumab 79
Nuove acquisizioni sul meccanismo di azione dei corticosteroidi. 78
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: VALUTAZIONE DI EFFICACIA E TOLLERABILITA' IN UNA CASISTICA DI TRENTA PAZIENTI 77
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast 76
Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma. 76
Monitoring of atmospheric conditions and forecast of olive pollen season. 76
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: PRESENTAZIONE DI UN CASO CLINICO 76
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties. 76
Purification and fine characterization of the major allergen from Olea europaea pollen extract. 75
Novel inibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 73
Fig and mulberry cross-allergy 73
Flaws and improvements in skin testing in hymenoptera venom allergy 73
Italian real-life experience of omalizumab. 73
Skin testing technique and precision in stinging insect allergy 72
Retrospective monitoring in the management of persistent asthma 72
Fennel (Foeniculum vulgare); a major allergen of the Mediterranean diet 72
Punti di debolezza ed ottimizzazione dei tests cutanei nell'allergia a veleno di imenotteri 71
Omalizumab e monitoraggio retrospettivo dei sintomi e del PEF nell'asma severo non controllato 70
Systemic adverse reaction to diclofenac administered by transdermal iontophoresis. 69
Indirect food contact in severe fish allergy. 69
Skin testing technique and precision in stinging insect allergy 69
Cyclooxygenase-2 expression in oral squamous cell carcinoma. 68
Management dell'anafilassi da alimenti 68
Tako-Tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 68
Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. 67
Tests cutanei nel monitoraggio dell'immunoterapia a veleno di imenotteri 67
Omalizumab and retrospective syntom score and PEF monitoring in severe asthma 66
Leukotriene biosyntesis inhibition and direct 5-lipoxygenase non competitive inhibition by the Cys-LT1 receptor antagonists montelukast ans zafirlukast. 66
Impact of Omalizumab in 21 patients with severe asthma 66
Novel food allergens of the Mediterranean diet. 66
Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak espiratory flow values before and after therapy. J Investig Allergol Clin Immunol; 65
Fennel (Foeniculum vulgare) allergy. Nico A, Vacca M, Bellotti A, Di Giacomo M, Giliberti A, Lotti A, Caiaffa MF, Macchia L. 65
Food Allergy in Southern Italy. Allergy to cynara scolymus 64
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) noncompetitive inhibition by the cys-LT1 receptor antagonist montelukast. 64
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 63
Terapia dell'asma severo con anticorpo monoclonale anti-IgE. Significativo declino dei valori di IgE specifiche legate, evidenziato da Skin Prick Tests Quantitativi. 61
Italian real-life experience of omalizumab 60
L'orticaria (da un punto di vista allergologico) 60
Studi "in vivo" sulla cross-reattività allergenica tra polline di Compositae anemofile e Compositae edibili 60
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 60
Desensitization in Iron Product Allergy 60
Efficacia e tollerabilità di Omalizumab (Xolair) dopo due anni di trattamento: studio in 17 soggetti con asma severo 59
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 59
Il ruolo organizzativo e pedagogico del Presidente di Corso di Laurea Magistrale in Medicina. 57
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 57
The lymphocyte proliferation test (LTP) in the diagnosis of critical cases of delayed drug allergy. 57
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 57
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 56
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and Cypress pollen 55
Retrospective monitoring in the management of persistent asthma. 55
Cost-effectiveness of grass pollen allergen immunotherapy in adults 54
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 54
Purification and fine characterization of the major allergen from Olea Europaea pollen extract. 53
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 53
Omalizumab in long-term treatment of refractory chronic spontaneous urticaria: effects of discontinuation. 52
Immunological characterization of onion (Allium cepa) allergy 52
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 52
Inibizione della via metabolica 5-lipossigenasica/leucotrienica da parte di sostanze antiossidanti di origine naturale 51
Totale 8.082
Categoria #
all - tutte 32.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019284 0 0 0 0 0 0 0 24 36 29 47 148
2019/20201.895 399 263 80 46 216 275 246 24 142 26 143 35
2020/20211.087 141 13 123 6 122 66 149 71 172 162 12 50
2021/2022715 102 1 7 23 62 21 26 53 98 70 33 219
2022/20233.061 242 114 121 161 148 247 56 315 1.444 43 102 68
2023/2024653 82 22 31 25 182 227 16 68 0 0 0 0
Totale 9.021